Brazil Records First Mpox Death of 2026 as Infections Exceed 1,000

Brazil has recorded its first death from mpox in 2026, as the country reports more than 1,000 confirmed infections and a rise in cases in recent months

Stay Connected, Stay Informed - Follow News Alert on WhatsApp for Real-time Updates!

Brazil has recorded its first death from mpox in 2026, as the country reports more than 1,000 confirmed infections and a rise in cases in recent months. The fatality occurred in Rio de Janeiro, where health authorities have reported an increase in infections, although officials say the current situation remains below the levels recorded during the major outbreak in 2022.

Rio de Janeiro Reports First Mpox Fatality

Brazilian health authorities confirmed the country’s first mpox-related death of the year in Rio de Janeiro.

According to Brazil’s Ministry of Health and local health officials, the victim was a 48-year-old man who had a pre-existing condition affecting his immune system. The underlying condition contributed to the deterioration of his health.

Authorities have not released further personal details about the patient, citing medical confidentiality and respect for the family’s privacy.

The death comes amid an increase in mpox infections in Rio de Janeiro and other parts of Brazil, prompting health authorities to strengthen disease surveillance.

More Than 1,000 Confirmed Cases Across Brazil

Brazil recorded 1,009 confirmed mpox infections in 2026, according to a report published by the Fiocruz Institute, which operates under the country’s Ministry of Health.

More recent figures from the ministry indicated that confirmed cases had reached 1,055 by November 13, while another 617 suspected infections remained under investigation.

São Paulo and Rio de Janeiro have reported the highest numbers of infections.

Rio de Janeiro has experienced a particularly noticeable increase in recent months. According to the state health department, 382 laboratory-confirmed cases had been recorded by November 13.

Of these, 124 were reported between January 1 and September 12, while another 258 were registered between September 13 and November 13.

The Brazilian authorities have strengthened monitoring measures in response to the increase. However, the Fiocruz Institute said the number of infections remained significantly below the historic peak recorded in 2022.

WHO Chief Urges Transparency Amid Russia Plague Reports

Brazil Secures Additional 25,000 Mpox Vaccine Doses

The Brazilian government has secured an additional 25,000 doses of the mpox vaccine to strengthen its national immunisation programme.

The Ministry of Health announced the purchase on November 8, with delivery expected within approximately three weeks.

The vaccination programme currently prioritises people considered at higher risk of developing serious complications, including certain laboratory workers handling the virus, immunocompromised people living with HIV/AIDS and individuals who have had medium- or high-risk contact with suspected or confirmed cases.

The recommended vaccination schedule consists of two doses administered 28 days apart.

Health authorities are also advising people to avoid direct physical contact with individuals showing suspected symptoms and to seek medical attention if unusual skin or mucosal lesions appear.

What Is Mpox and How Does It Spread?

Mpox is a viral infectious disease caused by the monkeypox virus, which belongs to the same virus family as smallpox.

The infection can spread from animals to humans and between people through close physical contact, particularly contact with infected skin lesions, bodily fluids or contaminated materials.

Common symptoms include fever, headaches, muscle aches, swollen lymph nodes, fatigue and skin lesions that can resemble boils or blisters.

Although many patients recover, the infection can cause serious complications and may be fatal, particularly among people with weakened immune systems.

The World Health Organization declared mpox a Public Health Emergency of International Concern in 2022 and again in 2024 following outbreaks in several countries.

The international emergency classification was lifted in September 2025, although health authorities continue to monitor the disease.

Brazil’s latest fatality has renewed attention on the importance of disease surveillance, vaccination among vulnerable groups and timely medical care as infections increase across parts of the country.

Sources: Agence France-Presse (AFP), Agência Brasil, Brazil’s Ministry of Health and Fiocruz Institute.

Leave a Comment

This material may not be published, broadcast, rewritten, redistributed or derived from.
Unless otherwise stated, all content is copyrighted © 2026 News Alert.